logo

PSNC News

  • MHRA Class 4 Medicines Defect Information: Etrivex 500 micrograms/g Shampoo (Galderma (U.K.) Limited)

    Class 4 Medicines Defect Information: Etrivex 500 micrograms/g Shampoo (Galderma (U.K.) Limited) Drug alert number: EL (22)A/51 Date issued: 06 December 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Etrivex 500 micrograms/g Shampoo, PL 10590/0052 – SNOMED code 11771611000001109 Batch number Expiry date Pack

    Read more

  • Manufacturer & Wholesaler Christmas Opening Hours 2022

    At this busy time of year manufacturers are working closely with wholesalers to ensure that sufficient stock is available at wholesalers for the Christmas period. A summary of customer service desk opening hours can be found in the table below. For information on order cut off /delivery schedules please see links at the bottom of the page.

    Read more

  • PSNC: Pharmacy needs funding if it is to help NHS

    Government suggestions to draft pharmacies in to help out during NHS strikes this winter are “categorically impossible” without extra funding, a PSNC Committee Member has warned. The Sunday Telegraph reported that community pharmacy teams could be drafted in to help the NHS to cope when other healthcare workers take industrial action. But while pharmacy has the skills and

    Read more

  • Reminder: Ordering arrangements for Inclisiran (Leqvio®)

    Contractors are reminded that Inclisiran (Leqvio®) is available to order from AAH UK at a nominal charge of £45 per pack, as agreed within the commercial agreement between Novartis and NHS England for supply against NHS prescriptions only.  AAH UK was awarded the tender for supply of Inclisiran (Leqvio®) to primary care in England under a

    Read more

  • MHRA Class 4 Medicines Defect Information: MacroBID 100mg Prolonged-Release Capsules (ADVANZ PHARMA)

    Class 4 Medicines Defect Information: MacroBID 100mg Prolonged-Release Capsules (ADVANZ PHARMA) Drug alert number: EL (22)A/50 Date issued: 05 December 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: MacroBID 100mg Prolonged-Release Capsules, PL 12762/0052 Batch Number Expiry Date Pack Size First Distributed 21001 05

    Read more

  • November 2022 Price Concessions Final Update

    The Department of Health and Social Care (DHSC) has today (02/12/2022) granted the following final list of price concessions for November 2022: Drug Pack size Price concession Nitrofurantoin 100mg tablets 28 £14.61 Nitrofurantoin 50mg tablets 28 £13.27 The DHSC previously announced (30/11/2022) the following list of price concessions: Drug Pack size Price concession Aripiprazole 5mg tablets 28

    Read more

  • Protecting Pharmacy Funding: A video update from PSNC’s CEO

    PSNC Chief Executive Janet Morrison has recorded a video update for community pharmacy contractors following PSNC’s November Committee meeting. Janet opens the video by emphasising that both PSNC staff and Committee Members know how difficult things are at the moment, and says that she wants to give some honest feedback on where the sector is

    Read more

  • Protecting Pharmacy Funding: PSNC seeks contractor views

    PSNC met last week and considered the critical situation facing many community pharmacy businesses as staffing and other costs continue to rise unchecked. Our ongoing priority is to make strong and urgent representations to Government to seek an emergency funding injection into the sector as well as relief from business rates. We are also discussing

    Read more

  • 5 products added to the Discount Not Deducted (DND) list from December 2022

    Following applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 5 new products will be classed as ‘Drugs for which Discount is Not Deducted’ (DND) from 1 December 2022. This takes the total number of products granted DND status over the past

    Read more

  • Medicine Supply Notification: Bupropion (Zyban® ) 150mg modified-release tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Bupropion (Zyban®) 150mg modified-release tablets. MSN/2022/100 Tier 3 – high impact Date of issue 1st December 2022 Bupropion (Zyban®) 150mg modified-release tablets will be out of stock until further notice. Various nicotine replacement therapies are available. NICE guidance highlights a range

    Read more
© 2025 Middlesex Pharmaceutical Group